Skip to main content
. 2017 Aug 1;102(4):448–454. doi: 10.1136/bjophthalmol-2017-310284

Table 2.

Correlation between cytokine concentrations before treatment and before the third ranibizumab injection

R p Value
CXCL1 0.51 0.0008
IP-10 0.64 <0.0001
CXCL12 0.36 0.0131
CXCL13 0.49 0.0004
MCP-1 0.77 <0.0001
CCL11 0.53 0.0001
IL-6 0.54 <0.0001
IL-10 −0.11 0.4759
MMP-9 0.35 0.0155

R, correlation coefficient.

CCL11, C-C motif chemokine ligand 11; CXCL1, C-X-C motif chemokine ligand 1; CXCL12, C-X-C motif chemokine ligand 12; CXCL13, C-X-C motif chemokine ligand 13; IL-6, interleukin-6; IL-10; interleukin-10; IP-10, interferon-γ-induced protein 10; MCP-1, monocyte chemoattractant protein 1; MMP-9, matrix metalloproteinase 9.